Degefa T.H., Kwak J. Aptamer Based Electrochemical Detection of Protein Using Biometallization // peerx-press.org/ms_files/ecsmeet2/2008/05/29/00002 472/00/ 2472_0_art_0_k1m8fk.pdf.
Dellaire G., Nisman R., Eskiw C.H., Bazett-Jones D.P. In situ imaging and isolation of proteins using dsDNA oligonucleotides // Nucleic Acids Res. 2004. V.32. P.e165.
Demarre G., Frumerie C., Gopaul D.N., Mazel D. Identification of key structural determinants of the IntI1 integron integrase that influence attC x attI1 recombination efficiency // Nucleic Acids Res. 2007. V.35. P.6475-6489.
Desai S.K., Gallivan J.P. Genetic screens and selections for small molecules based on a synthetic riboswitch that activates protein translation // J. Am. Chem. Soc. 2004. V.126. P.13247–13254.
de Smidt P.C., Le Doan T., de Falco S., van Berkel T.J. Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution // Nucleic Acids Res. 1991. V.19. P.4695-4700.
DeStefano J.J., Cristofaro J.V. Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity // Nucleic Acids Res. 2006. V.34. P.130-139.
Dey A.K., Griffiths C., Lea S.M., James W. Structural characterization of an antigp120 RNA aptamer that neutralizes R5 strains of HIV-1 // RNA. 2005. V.11. P.873-884.
Dey A.K., Khati M., Tang M., Wyatt R., Lea S.M., James W. An Aptamer That Neutralizes R5 Strains of Human Immunodeficiency Virus Type 1 Blocks gp120-CCR5 Interaction // J. Virol. 2005. V.79. P.13806-13810.
Dieckmann T., Butcher S.E., Sassanfar M., Szostak J.W., Feigon J. Mutant ATP-binding RNA aptamers reveal the structural basis for ligand binding // J. Mol. Biol. 1997. V.273. P.467–478.
Dieckmann T., Suzuki E., Nakamura G.K., Feigon J. Solution structure of an ATP-binding RNA aptamer reveals a novel fold // RNA. 1996. V.2. P.628–640.
Doern C.D., Holder R.C., Reid S.D. Point mutations within the streptococcal regulator of virulence (Srv) alter protein-DNA interactions and Srv function // Microbiology. 2008. V.154. P.1998-2007.
Doreleijers J.F., Mading S., Maziuk D., Sojourner K., Yin L., Zhu J., Markley J.L., Ulrich E.L. BioMagResBank database with sets of experimental NMR constraints corresponding to the structures of over 1400 biomolecules deposited in the Protein Data Bank // J. Biomol. NMR. 2003. V.26. P.139–146.
Dosset P., Hus J.C., Marion D., Blackledge M. A novel interactive tool for rigid-body modeling of multi-domain macro-molecules using residual dipolar couplings // J. Biomol. NMR. 2001. V.20. P.223–231.
Doudna J.A., Cech T.R., Sullenger B.A. Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor // Proc. Natl. Acad. Sci. USA. 1995. V.92. P.2355–2359.
Dougan H., Lyster D.M., Vo C.V., Stafford A., Weitz J.I., Hobbs J.B. Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood // Nucl. Med. Biol. 2000. V.27. P.289-297.
Drabovich A.P., Berezovski M., Okhonin V., Krylov S.N. Selection of smart aptamers by methods of kinetic capillary electrophoresis // Anal. Chem. 2006. V.78. P.3171-3178.
Drolet D.W., Jenison R.D., Smith D.E., Pratt D., Hicke B.J. A high throughput platform for systematic evolution of ligands by exponential enrichment (SELEX) // Comb. Chem. High Throughput Screen. 1999. V.2. P.271-278.
Drolet D.W., Moon-McDermott L., Romig T.S. An enzyme-linked oligonucleotide assay // Nat. Biotechnol. 1996. V.14. P.1021–1025.
Drolet D.W., Nelson J., Tucker C.E., Zack P.M., Nixon K., Bolin R., Judkins M.B., Farmer J.A., Wolf J.L., Gill S.C., Bendele R.A. Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys // Pharm. Res. 2000. V.17. P.1503–1510.
Dubey A.K., Baker C.S., Romeo T., Babitzke P. RNA sequence and secondary structure participate in high-affinity CsrA-RNA interaction // RNA. 2005. V.11. P.1579-1587.
Duconge F., Toulme J.J. In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1 // RNA. 1999. V.5. P.1605-1614.
Duhamel J., Liu D.M., Evilia C., Fleysh N., Dinter-Gottlieb G., Lu P. Secondary structure content of the HDV ribozyme in 95% formamide // Nucleic Acids Res. 1996. V.24. P.3911–3917.
Eaton B.E., Gold L., Zichi D.A. Let's get specific: the relationship between specificity and affinity // Chem. Biol. 1995. V.2. P.633–638.
Eder P., DeVine R., Dagle J., Walder J. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma // Antisense Res. Dev. 1991. V.1. P.141–151.
Edwards T.E., Ferreé-D’Amaré A. Crystal structures of the Thi-box riboswitch bound to thiamine pyrophosphate analogs reveal adaptive RNA-small molecule recognition // Structure. 2006. V.14. P.1459–1468.
Ehresmann C., Baudin F., Mogel M., Romby P., Ebel J.-P., Ehresmann B. Probing the structure of RNAs in solution // Nucleic Acids Res. 1987. V.15. P.9109–9128.
Ekland E.H., Szostak J.W., Bartel D.P. Structurally complex and highly active RNA ligases derived from random RNA sequences // Science. 1995. V.269. P.364-370.
Ellingham M., Bunka D.H.J., Rowlands D.J., Stonehouse N.J. Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus // RNA. 2006. V.12. P.1970 - 1979.
Ellington A.D., Szostak J.W. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures // Nature. 1992. V.355. P.850–852.
Elnitski L., Jin V.X., Farnham P.J., Jones S.J.M. Locating mammalian transcription factor binding sites: A survey of computational and experimental techniques // Genome Res. 2006. V.16. P.1455-1464.
Epshtein V., Mironov A.S., Nudler E. The riboswitch-mediated control of sulfur metabolism in bacteria // Proc. Natl Acad. Sci. USA. 2003. V.100. P.5052–5056.
Erickson H.P., Bourdon M.A. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors // Annu. Rev. Cell Biol. 1989. V.5. P.71–92.
Eulberg D., Buchner K., Maasch C., Klussmann S. Development of an automated in vitro selection protocol to obtain RNA-based aptamers: Identification of a biostable substance P antagonist // Nucleic Acids Res. 2005. V.33. P.e45.
Eulberg D., Klussmann S. Spiegelmers: biostable aptamers // Chembiochem. 2003. V.4. P.979–983.
Famulok M. Oligonucleotide aptamers that recognize small molecules // Curr. Opin. Struct. Biol. 1999. V.9. P.324–329.
Famulok M. Molecular Recognition of Amino Acids by RNA-Aptamers: An LCitrulline Binding Motif and Its Evolution into an L-Arginine Binder // J. Am. Chem. Soc. 1994. V.116. P.1698-1706.
Famulok M., Blind M., Mayer G. Intramers as promising new tools in functional proteomics // Chem. Biol. 2001. V.8. P.931-939.
Famulok M., Hüttenhofer A. // Biochemistry. 1996. V.35. P.4265.
Famulok M., Mayer G. Aptamers as tools in molecular biology and immunology // Curr. Top. Microbiol. Immunol. 1999. V.243. P.123–136.
Famulok M., Szostak J.W. Stereospecific Recognition of Tryptophan Agarose by in Vitro Selected RNA // J. Am. Chem. Soc. 1992. V.114. P.3990-3991.
9. Famulok M., Verma S. In vivo applied functional RNAs as tools in proteomics and genomics research // Trends Biotechnol. 2002. V.20. P.462–466.
Fan P., Suri A., Fiala R., Live D., Patel D. Molecular recognition in the FMN-RNA aptamer complex // J. Mol. Biol. 1996. V.258. P.480–500.
Farokhzad O.C., Cheng J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., Richie J.P., Langer R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo // PNAS. 2006. V.103. P.6315-6320.
Feig A.L., Uhlenbeck O.C. The role of metal ions in RNA biochemistry // R.F. Gesteland et al., Eds. The RNA world, 2d ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1999. P.287-319.
Faulhammer D., Eschgfäller B., Stark S., Burgstaller P., Englberger W., Erfurth J., Kleinjung F., Rupp J., Dan Vulcu S., Schröder W., Vonhoff S., Nawrath H., Gillen C., Klussmann S. Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ // RNA. 2004. V.10. P.516-527.
Fauzi H., Jack K.D., Hines J.V. In vitro selection to identify determinants in tRNA for Bacillus subtilis tyrS T box antiterminator mRNA binding // Nucleic Acids Res. 2005. V.33. P.2595-2602.
Feigon J., Dieckmann T., Smith F.W. Aptamer structures from A to zeta // Chem. Biol. 1996. V.3. P.611–617.
Ferguson A., Boomer R.M., Kurz M., Keene S.C., Diener J.L., Keefe A.D., Wilson C., Cload S.T. A novel strategy for selection of allosteric ribozymes yields RiboReporterTM sensors for caffeine and aspartame // Nucleic Acids Research. 2004. V.32. P.1756-1766.
Ferré-D’Amaré A.R., Zhou K., Doudna J.A. Crystal structure of a hepatitis delta virus ribozyme // Nature. 1998. V.395. P.567–574.
Ferreira C.S., Matthews C.S., Missailidis S. DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers // Tumor Biol. 2006. V.27. P.289-301.
Fiammengo R., Jäschke A. Nucleic acid enzymes // Curr. Opin. Biotechnol. 2005. V.16. P.614–621.
Fiammengo R., Musilek K., Jäschke A. Efficient preparation of organic substrate-RNA conjugates via in vitro transcription // J. Am. Chem. Soc. 2005. V.127. P.9271–9276.
Fitzwater T., Polisky B. A SELEX primer // Methods Enzymol. 1996. V.267. P.275-301.
Flinders J., DeFina S.C., Brackett D.M., Baugh C., Wilson C., Dieckmann T. Recognition of planar and nonplanar ligands in the malachite green-RNA aptamer complex // ChemBioChem. 2004. V.5. P.62-72.
Flynn-Charlebois A., Lee N., Suga H. A single metal ion plays structural and chemical roles in an aminoacyl-transferase ribozyme // Biochemistry. 2001. V.40. P.13623-13632.
Flynn-Charlebois A., Prior T.K., Hoadley K.A., Silverman S.K. In Vitro Evolution of an RNA-Cleaving DNA Enzyme into an RNA Ligase Switches the Selectivity from 3'-5' to 2'-5' // J. Am. Chem. Soc. 2003. V.125. P.5346-5350.
Flynn-Charlebois A., Wang Y., Prior T.K., Rashid I., Hoadley K.A., Coppins R.L., Wolf A.C., Silverman S.K. Deoxyribozymes with 2'-5' RNA Ligase Activity // J. Am. Chem. Soc. 2003. V.125. P.2444-2454.
Forster A.C., Symons R.H. Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites // Cell. 1987. V.49. P.211–220. |
Fraternali F., Cavallo L. Parameter optimized surfaces (POPS): Analysis of key interactions and conformational changes in the ribosome // Nucleic Acids Res. 2002. V.30. P.2950–2960.
Frieden M., Christensen S.M., Mikkelsen N.D., Rosenbohm C., Thrue C.A., Westergaard M., Hansen H.F., Orum H., Koch T. Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA // Nucleic Acids Res. 2003. V.31. P.6365–6372.
Fuchs R.T., Grundy F.J., Henkin T.M. S-adenosylmethionine directly inhibits binding of 30S ribosomal subunits to the SMK box translational riboswitch RNA // PNAS. 2007. V.104. P.4876–4880.
Fukuda K., Vishnuvardhan D., Sekiya S., Hwang J., Kakiuchi N., Taira K., Shimotohno K., Kumar P.K.R., Nishikawa S. Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease // Eur. J. Biochem. 2000. V.267. P.3685–3694.
Fusz S., Eisenfuhr A., Srivatsan S.G., Heckel A., Famulok M. A ribozyme for the aldol reaction // Chem. Biol. 2005. V.12. P.941-950.
Gan H.H., Pasquali S., Schlick T. Exploring the repertoire of RNA secondary motifs using graph theory; implications for RNA design // Nucleic Acids Res. 2003. V.31. P.2926-2943.
Guntas G., Mansell T.J., Kim J.R., Ostermeier M. Directed evolution of protein switches and their application to the creation of ligand-binding proteins // PNAS. 2005. V.102. P.11224-11229.
Garrey S.M., Voelker R., Berglund J.A. An Extended RNA Binding Site for the Yeast Branch Point-binding Protein and the Role of Its Zinc Knuckle Domains in RNA Binding // J. Biol. Chem. 2006. V.281. P.27443-27453.
Gebhardt K., Shokraei A., Babaie E., Lindqvist B.H. RNA aptamers to S-adenosylhomocysteine: kinetic properties, divalent cation dependency, and comparison with anti-S-adenosylhomocysteine antibody // Biochemistry. 2000. V.39. P.7255–7265.
Geiger A., Burgstaller P., Eltz H.V., Roeder A., Famulok M. RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity // Nucleic Acids Res. 1996. V.24. P.1029–1036.
Gening L.V., Klincheva S.A., Reshetnjak A., Grollman A.P., Miller H. RNA aptamers selected against DNA polymerase {beta} inhibit the polymerase activities of DNA polymerases beta and kappa // Nucleic Acids Res. 2006. V.34. P.2579-2586.
Gevertz J., Gan H.H., Schlick T. In vitro RNA random pools are not structurally diverse: A computational analysis // RNA. 2005. V.11. P.853–863.
Geyer C.R., Sen D. Evidence for the metal-cofactor independence of an RNA phosphodiester-cleaving DNA enzyme // Chem. Biol. 1997. V.4. P.579-593.
Gianneschi N.C., Masar M.S., III, Mirkin C.A. Development of a coordination chemistry-based approach for functional supramolecular structures // Acc. Chem. Res. 2005. V.38. P.825–837.
Giangrande P.H., Zhang J., Tanner A., Eckhart A.D., Rempel R.E., Andrechek E.R., Layzer J.M., Keys J.R., Hagen P.-O., Nevins J.R., et al. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia // PNAS. 2007. V.104. P.12988-12993.
Gietz R.D., Woods R.A. Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method // Methods Enzymol. 2002. V.350. P.87–96.
Giver L., Bartel D., Zapp M., Pawul A., Green M., Ellington A.D. Selective optimization of the Rev-binding element of HIV-1 // Nucleic Acids Res. 1993. V.23. P.5509-5516.
Giver L., Bartel D.P., Zapp M.L., Green M.R., Ellington A.D. Selection and design of high-affinity RNA ligands for HIV-1 // Rev. Gene. 1993. V.137. P.19-24.
13. Gold L., Polisky B., Uhlenbeck O., Yarus M. Diversity of oligonucleotide functions // Annu. Rev. Biochem. 1995. V.64. P.763–797.
Golden M.C., Collins B.D., Willis M.C., Koch T.H. Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers // J. Biotechnol. 2000. V.81. P.167-178.
Golden B.L., Gooding A.R., Podell E.R., Cech T.R. A preorganized active site in the crystal structure of the Tetrahymena ribozyme // Science. 1998. V.282. P.259-264. |
Gopinath S.C.B., Balasundaresan D., Akitomi J., Mizuno H. An RNA Aptamer That Discriminates Bovine Factor IX from Human Factor IX // Journal of Biochemistry. 2006. V.140. P.667-676.
Gopinath S.C.B., Misono T., Kawasaki K., Mizuno T., Imai M., Odagiri T., Kumar P.K.R. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits hemagglutinin-mediated membrane fusion // J. Gen. Virol. 2006. V.87. P.479–487.
Gopinath S.C.B., Sakamaki Y., Kawasaki K., Kumar P.K.R. An Efficient RNA Aptamer against Human Influenza B Virus Hemagglutinin // J. Biochem. 2006. V.139. P.837-846.
Gopinath S.C.B., Shikamoto Y., Mizuno H., Kumar P.K.R. A potent anti-coagulant RNA aptamer inhibits blood coagulation by blocking specifically an extrinsic clotting pathway // Thromb. Haemost. 2006. V.95. P.767–771.
Göringer H.U., Homann M., Lorger M. In vitro selection of high-affinity nucleic acid ligands to parasite target molecules // Int. J. Parasitol. 2003. V.33. P.1309–1317.
Göringer H.U., Homann M., Zacharias M., Adler A. RNA aptamers as potential pharmaceuticals against infections with African trypanosomes // Handb. Exp. Pharmacol. 2006. V.173. P.375–393.
Gossett A.J., Lieb J.D. DNA Immunoprecipitation (DIP) for the Determination of DNA-Binding Specificity // CSH Protocols 2008, pdb.prot4972.
Grate D., Wilson C. Laser-mediated, site-specific inactivation of RNA transcripts // Proc. Natl. Acad. Sci. USA. 1999. V.96. P.6131-6136.
Green L., Waugh S., Binkley J.P., Hostomska Z., Hostomsky Z., Tuerk C. Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase // J. Mol. Biol. 1995. V.247. P.60-68.
Green L.S., Jellinek D., Bell C., Beebe L.A., Feistner B.D., Gill S.C., Jucker F.M., Janjic N. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor // Chem. Biol. 1995. V.2. P.683–695.
Green L.S., Jellinek D., Jenison R., Ostman A., Heldin C.H., Janjic N. Inhibitory DNA ligands to platelet-derived growth factor B-chain // Biochemistry. 1996. V.35. P.14413-14424.
Grosshans C.A., Cech T.R. A hammerhead ribozyme allows synthesis of a new form of the Tetrahymena ribozyme homogeneous in length with a 3' end blocked for transesterification // Nucleic Acids Res. 1991 V.19. P.3875–3880.
Grunweller A., Wyszko E., Bieber B., Jahnel R., Erdmann V.A., Kurreck J. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA // Nucleic Acids Res. 2003. V.31. P.3185–3193.
Gugliotti L.A., Feldheim D.L., Eaton B.E. RNA-mediated metal-metal bond formation in the synthesis of hexagonal palladium nanoparticles // Science. 2004. V.304. P.850-852.
Gugliotti L.A., Feldheim D.L., Eaton B.E. RNA-mediated control of metal nanoparticle shape // J. Am. Chem. Soc. 2005. V.127. P.17814-17818.
Guo K.-T., Schafer R., Paul A., Gerber A., Ziemer G., Wendel H.P.. A New Technique for the Isolation and Surface Immobilization of Mesenchymal Stem Cells from Whole Bone Marrow Using High-Specific DNA Aptamers // Stem. Cells. 2006. V.24. P.2220-2231.
Hager A.J., Szostak J.W. Isolation of novel ribozymes that ligate AMP-activated RNA substrates // Chem. Biol. 1997. V.4. P.607-617.
Hale S.P., Schimmel P. Protein synthesis editing by a DNA aptamer // Proc. Natl. Acad. Sci. USA. 1996. V.93. P.2755-2758.
Haller A.A., Sarnow P. In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules // Proc. Natl Acad. Sci. USA. 1997. V.94. P.8521–8526.
Hamasaki K., Killian J., Cho J., Rando R.R. Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities // Biochemistry. 1998. V.
